Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bossi

Showing results (131-140 of 151) with videos related to

Pageof 16
Sort By:
ESMO Open|April 30, 2024
Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical OncologyP Queirolo, M Cinquini, G Argenziano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 15, 2011
Docetaxel, cisplatin and 5-fluorouracil-based induction chemotherapy followed by intensity-modulated radiotherapy concurrent with cisplatin in locally advanced EBV-related nasopharyngeal cancerP Bossi, E Orlandi, C Bergamini, et al.
ESMO Open|October 28, 2025
Validation of a prognostic nomogram for locally advanced oropharyngeal carcinoma treated with intensity-modulated radiotherapy with/without systemic therapyP Bossi, R Gili, S Calza, et al.
HIV Medicine|September 17, 2004
GENOPHAR: a randomized study of plasma drug measurements in association with genotypic resistance testing and expert advice to optimize therapy in patients failing antiretroviral therapyP Bossi, G Peytavin, H Ait-Mohand, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 26, 2011
Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation studyR Granata, R Miceli, E Orlandi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 2, 2017
A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatinP Bossi, D Cortinovis, S Fatigoni, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 28, 2020
Prediction of mucositis risk secondary to cancer therapy: a systematic review of current evidence and call to actionH R Wardill, S T Sonis, N M A Blijlevens, et al.
The American Journal of Medicine|November 27, 1998
Acquired hemophilia due to factor VIII inhibitors in 34 patientsP Bossi, J Cabane, J Ninet, et al.
European Journal of Cancer (Oxford, England : 1990)|May 8, 2018
Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancerS Cavalieri, F Perrone, R Miceli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neckP Bossi, R Miceli, L D Locati, et al.
Pageof 16

Showing results (131-140 of 151) with videos related to

Sort By:
Pageof 16
ESMO Open|April 30, 2024
Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical OncologyP Queirolo, M Cinquini, G Argenziano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 15, 2011
Docetaxel, cisplatin and 5-fluorouracil-based induction chemotherapy followed by intensity-modulated radiotherapy concurrent with cisplatin in locally advanced EBV-related nasopharyngeal cancerP Bossi, E Orlandi, C Bergamini, et al.
ESMO Open|October 28, 2025
Validation of a prognostic nomogram for locally advanced oropharyngeal carcinoma treated with intensity-modulated radiotherapy with/without systemic therapyP Bossi, R Gili, S Calza, et al.
HIV Medicine|September 17, 2004
GENOPHAR: a randomized study of plasma drug measurements in association with genotypic resistance testing and expert advice to optimize therapy in patients failing antiretroviral therapyP Bossi, G Peytavin, H Ait-Mohand, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 26, 2011
Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation studyR Granata, R Miceli, E Orlandi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 2, 2017
A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatinP Bossi, D Cortinovis, S Fatigoni, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 28, 2020
Prediction of mucositis risk secondary to cancer therapy: a systematic review of current evidence and call to actionH R Wardill, S T Sonis, N M A Blijlevens, et al.
The American Journal of Medicine|November 27, 1998
Acquired hemophilia due to factor VIII inhibitors in 34 patientsP Bossi, J Cabane, J Ninet, et al.
European Journal of Cancer (Oxford, England : 1990)|May 8, 2018
Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancerS Cavalieri, F Perrone, R Miceli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neckP Bossi, R Miceli, L D Locati, et al.
Pageof 16